H-D-Phe(2-trifluoromethyl)-OH
Need Assistance?
  • US & Canada:
    +
  • UK: +

H-D-Phe(2-trifluoromethyl)-OH

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Fluorinated amino acids
Catalog number
BAT-005556
CAS number
130930-49-3
Molecular Formula
C10H10F3NO2
Molecular Weight
233.19
H-D-Phe(2-trifluoromethyl)-OH
IUPAC Name
(2R)-2-amino-3-[2-(trifluoromethyl)phenyl]propanoic acid
Synonyms
D-Phe(2-CF3)-OHo-Trifluoromethyl-D-phenylalanine; (R)-2-Amino-3-(2-trifluoromethyl-phenyl)propionic acid
Appearance
White powder
Purity
≥ 99% (HPLC, Chiral purity)
Density
1.364±0.06 g/cm3
Boiling Point
299.4±40.0 °C
Storage
Store at 2-8°C
InChI
InChI=1S/C10H10F3NO2/c11-10(12,13)7-4-2-1-3-6(7)5-8(14)9(15)16/h1-4,8H,5,14H2,(H,15,16)/t8-/m1/s1
InChI Key
IOABLDGLYOGEHY-MRVPVSSYSA-N
Canonical SMILES
C1=CC=C(C(=C1)CC(C(=O)O)N)C(F)(F)F
1.fMLP-induced arachidonic acid release in db-cAMP-differentiated HL-60 cells is independent of phosphatidylinositol-4, 5-bisphosphate-specific phospholipase C activation and cytosolic phospholipase A(2) activation.
Sternfeld L1, Thévenod F, Schulz I. Arch Biochem Biophys. 2000 Jun 15;378(2):246-58.
In inflammatory cells, agonist-stimulated arachidonic acid (AA) release is thought to be induced by activation of group IV Ca(2+)-dependent cytosolic phospholipase A(2) (cPLA(2)) through mitogen-activated protein kinase (MAP kinase)- and/or protein kinase C (PKC)-mediated phosphorylation and Ca(2+)-dependent translocation of the enzyme to the membrane. Here we investigated the role of phospholipases in N-formylmethionyl-l-leucyl-l-phenylalanine (fMLP; 1 nM-10 microM)-induced AA release from neutrophil-like db-cAMP-differentiated HL-60 cells. U 73122 (1 microM), an inhibitor of phosphatidyl-inositol-4,5-biphosphate-specific phospholipase C, or the membrane-permeant Ca(2+)-chelator 1, 2-bis¿2-aminophenoxyĕthane-N,N,N',N'-tetraacetic acid (10 microM) abolished fMLP-mediated Ca(2+) signaling, but had no effect on fMLP-induced AA release. The protein kinase C-inhibitor Ro 318220 (5 microM) or the inhibitor of cPLA(2) arachidonyl trifluoromethyl ketone (AACOCF(3); 10-30 microM) did not inhibit fMLP-induced AA release.
2.Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions.
Tsai BS1, Keith RH, Villani-Price D, Haack RA, Bauer RF, Leonard R, Abe Y, Nicolaou KC. Prostaglandins. 1989 Feb;37(2):287-302.
A leukotriene B4 (LTB4) analog, 20-trifluoromethyl LTB4 (20CF3-LTB4), has been synthesized and evaluated with human neutrophils for effects on chemotaxis and degranulation. 20CF3-LTB4 was equipotent to LTB4 as a chemoattractant (EC50, 3 nM), produced 50% of maximal activity of LTB4, and competed with [H] LTB4 for binding to intact human neutrophil LTB4 receptors. In contrast to chemotactic activity, 20CF3-LTB4 in nanomolar concentrations exhibited antagonist activity without agonist activity up to 10 microM on LTB4-induced degranulation. The analog had no significant effect on degranulation induced by the chemoattractant peptide, N-formyl-methionyl-leucyl-phenylalanine (fMLP). Like LTB4, 20CF3-LTB4 induced neutrophil desensitization to degranulation by LTB4. The results indicate that hydrogen atoms at C-20 of LTB4 are critical for its intrinsic chemotactic and degranulation activities. The fact that 20CF3-LTB4 is a partial agonist for chemotaxis and an antagonist for degranulation suggests that different LTB4 receptor subtypes are coupled to these neutrophil functions.
Online Inquiry
Verification code
Inquiry Basket